JP2009526794A5 - - Google Patents

Download PDF

Info

Publication number
JP2009526794A5
JP2009526794A5 JP2008554654A JP2008554654A JP2009526794A5 JP 2009526794 A5 JP2009526794 A5 JP 2009526794A5 JP 2008554654 A JP2008554654 A JP 2008554654A JP 2008554654 A JP2008554654 A JP 2008554654A JP 2009526794 A5 JP2009526794 A5 JP 2009526794A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
independently
group
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008554654A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009526794A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/001213 external-priority patent/WO2007093365A2/en
Publication of JP2009526794A publication Critical patent/JP2009526794A/ja
Publication of JP2009526794A5 publication Critical patent/JP2009526794A5/ja
Pending legal-status Critical Current

Links

JP2008554654A 2006-02-15 2007-02-13 新規なアミノアルコール置換アリールチエノピリミジノン、それらの製造方法及び薬剤としてそれらの使用 Pending JP2009526794A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006007049 2006-02-15
PCT/EP2007/001213 WO2007093365A2 (en) 2006-02-15 2007-02-13 Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments

Publications (2)

Publication Number Publication Date
JP2009526794A JP2009526794A (ja) 2009-07-23
JP2009526794A5 true JP2009526794A5 (https=) 2010-04-02

Family

ID=38069213

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008554654A Pending JP2009526794A (ja) 2006-02-15 2007-02-13 新規なアミノアルコール置換アリールチエノピリミジノン、それらの製造方法及び薬剤としてそれらの使用

Country Status (13)

Country Link
US (1) US8853208B2 (https=)
EP (1) EP1987042B1 (https=)
JP (1) JP2009526794A (https=)
KR (1) KR20080096670A (https=)
CN (1) CN101384605A (https=)
AR (1) AR059520A1 (https=)
AU (1) AU2007214710A1 (https=)
BR (1) BRPI0707870A2 (https=)
CA (1) CA2636879A1 (https=)
IL (1) IL193342A0 (https=)
TW (1) TW200801022A (https=)
UY (1) UY30164A1 (https=)
WO (1) WO2007093365A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA92083C2 (ru) * 2006-05-19 2010-09-27 Эбботт Леборетриз Азабициклические алкановые производные, замещенные конденсированным бициклогетероциклом
WO2010003624A2 (en) 2008-07-09 2010-01-14 Sanofi-Aventis Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2011011303A1 (en) 2009-07-21 2011-01-27 Gilead Sciences, Inc. Inhibitors of flaviviridae viruses
ES2559437T3 (es) 2009-09-09 2016-02-12 Gilead Sciences, Inc. Inhibidores de virus de la familia Flaviviridae
AP3576A (en) 2010-01-15 2016-02-08 Gilead Sciences Inc Inhibitors of flaviviridae viruses
CA2785563C (en) 2010-01-15 2019-05-14 Gilead Sciences, Inc. Inhibitors of flaviviridae viruses
HUP1100241A3 (en) 2011-05-06 2013-12-30 Richter Gedeon Nyrt Oxetane substituted pyrimidones
AU2012280959B2 (en) 2011-07-13 2015-08-06 Gilead Sciences, Inc. Thiophen-2-carboxylic acid derivatives useful as inhibitors of Flaviviridae viruses
US8841340B2 (en) 2012-08-17 2014-09-23 Gilead Sciences, Inc. Solid forms of an antiviral compound
US8759544B2 (en) 2012-08-17 2014-06-24 Gilead Sciences, Inc. Synthesis of an antiviral compound
US8927741B2 (en) 2012-08-17 2015-01-06 Gilead Sciences, Inc. Synthesis of an antiviral compound
JP7114076B2 (ja) 2015-12-22 2022-08-08 シャイ・セラピューティクス・エルエルシー がん及び炎症性疾患の処置のための化合物
JP7514005B2 (ja) 2017-06-21 2024-07-10 シャイ・セラピューティクス・エルエルシー がん、炎症性疾患、ラソパシー、及び線維性疾患の治療のためのrasスーパーファミリーと相互作用する化合物
JP7407461B2 (ja) 2018-12-19 2024-01-04 シャイ・セラピューティクス・エルエルシー がん、炎症性疾患、ras病、及び線維性疾患の処置のためのrasスーパーファミリーと相互作用する化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124627D0 (en) * 2001-10-15 2001-12-05 Smithkline Beecham Plc Novel compounds
NZ532597A (en) * 2001-11-13 2006-04-28 Emisphere Tech Inc Phenoxy amine compounds and compositions for delivering active agents
DE10233817A1 (de) * 2002-07-25 2004-02-12 Aventis Pharma Deutschland Gmbh Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10238865A1 (de) * 2002-08-24 2004-03-11 Boehringer Ingelheim International Gmbh Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
WO2004052371A2 (en) * 2002-12-11 2004-06-24 7Tm Pharma A/S Cyclic quinoline compounds for use in mch receptor related disorders
DE10306250A1 (de) * 2003-02-14 2004-09-09 Aventis Pharma Deutschland Gmbh Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US20070078125A1 (en) * 2003-10-23 2007-04-05 Glaxo Group Limited Arylamine mch r1 antagonists
WO2005085200A1 (ja) * 2004-03-05 2005-09-15 Banyu Pharmaceutical Co., Ltd. ピリドン誘導体
US20050256124A1 (en) * 2004-04-15 2005-11-17 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto

Similar Documents

Publication Publication Date Title
JP2009526794A5 (https=)
JP2009526792A5 (https=)
JP2009526793A5 (https=)
JP2009526795A5 (https=)
RU2008136898A (ru) Азациклил-замещенные арилдигидроизохинолиноны, способ их получения и их применение в качестве лекарственных средств
CY1120342T1 (el) Ανταγωνιστης πολυκυκλικου lpa1 και χρησεις εξ' αυτου
US8461191B2 (en) Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
ES2654615T3 (es) Compuestos de carbamato para el tratamiento del trastorno bipolar
ES2573715T3 (es) Ligandos sigma para la prevención y/o el tratamiento del vómito inducido por la quimioterapia o la radioterapia
WO2011159550A3 (en) Lysophosphatidic acid receptor antagonist and uses thereof
JP2006501202A5 (https=)
RU2007120454A (ru) Производные хинуклидина и их применение в качестве антагонистов мускариновых рецепторов м3
CN104487429A (zh) 杂环黄酮衍生物、组合物及与其相关的方法
RU2624446C2 (ru) Трициклические соединения, композиции, содержащие указанные соединения, и их применения
JP2012523395A5 (https=)
BR112020010429A2 (pt) uso de agonista de kor em combinação com agonista de mor na preparação de fármaco para tratamento da dor
RU2011145054A (ru) Кристаллические формы саксаглиптина
RU2009135016A (ru) Твердые формы, содержащие (-)-о-десметилвенлафаксин, и их применения
BRPI0519287A2 (pt) derivados de amida
ES2820511T3 (es) Ureas asimétricas p-sustituidas y usos médicos de las mismas
JP2023500857A (ja) 新規な化合物およびそれを含むがんの予防または治療用薬学組成物
US20180042922A1 (en) Compositions and methods of treating a neurodegenerative disease
ES2992773T3 (en) Use of thyroid beta-agonists
ES2665293T3 (es) Compuesto para tratar estados con mediación alfa-adrenérgica
CN105497019A (zh) 胺类化合物治疗疼痛的医药用途